Skip to main content

Government report slams Theranos for quality control, unqualified personnel

Government report slams Theranos for quality control, unqualified personnel


Unlicensed personnel reviewed and released patient test results

Share this story

Photo by Kimberly White/Getty Images for Fortune

Theranos' blood tests often failed to meet the lab's own standards, a redacted inspection report released by the US Centers for Medicare and Medicaid Services revealed today. Theranos also employed unqualified staff and had them review patient test results. Because of this, and other errors, a Theranos lab posed "immediate jeopardy to patient safety."

"We’ve made mistakes in the past."

Despite not having completed the proper training, members of Theranos' Newark, California laboratory staff ran and reported test results to patients over a period of months in 2015. The document also reveals that Theranos put its customers at risk when it failed to have a manual on hand that outlined the actions staff needed to take when quality control results didn't meet the lab's own criteria. In addition, Theranos failed to document calibration of the machine it uses for hematology tests. It also didn't ensure proper quality control for a test used to determine how long blood takes to clot before reporting results to patients. A CMS spokesperson declined to elaborate on the contents of the document.

"We’ve made mistakes in the past in the Newark lab," Theranos spokesperson Brooke Buchanan told The Verge in an emailed statement. "But when the company was made aware of the deficiencies," Theranos "dedicated every resource to remedy those failures."

The 147-page redacted report that the US government sent to The Verge late today describes the results of an inspection that occurred in November 2015. It comes two months after the public release of a letter that CMS sent to Theranos at the end of January. The letter stated that the blood-testing company had 10 days to take action and fix deficiencies identified by inspectors during the inspection that ended in December. If Theranos failed to fix these issues, its lab could have lost its certification and CMS could have canceled its approval for Medicare payments, forcing the lab to shut down. CMS also said that it could fine the company up to $10,000 for each day that the lab was non-compliant. Some of the information contained in the inspection report was previously reported by The Wall Street Journal, but until now the exact nature of the deficiencies found at Theranos' Newark lab had not been made public. Today's report, which The Wall Street Journal has obtained in full, reveals just how careless Theranos was with its tests and the way it managed personnel.

One testing staff member had a bachelor's degree in "Liberal Studies"

Out of the 11 testing personnel files that US officials reviewed, eight "did not include any documentation of training" for a device prior to running patient blood tests on that device (the document was redacted at Theranos' request, so it's unclear which machine it was referred to). In addition, two out of three technical supervisors couldn't produce documentation showing that they had the right training for hematology or immunology tests. The inspectors also found that between June 1st and September 21st, 2015, unlicensed staff members reviewed patients' test results — even though the lab "has a sufficient number of individuals who meet the qualification requirements," the report states. One member of Theranos' testing staff, for instance, had a bachelor's degree in "Liberal Studies," inspectors noted.

The redacted report also appears to substantiate the conclusions of a study published this week, which showed that results from some of Theranos' blood tests are systematically lower than they should be. In the case of the blood clotting test, quality control data showed that patient test results were "lower than it should have been reported," the report states.

Theranos' inventions performed poorly

In addition, the unredacted report that the WSJ obtained shows that 13 tests conducted on Theranos' inventions have been performing poorly. For instance, 29 percent of the quality control checks performed on the company's inventions in October 2014 fell outside the normal range. In early February, a hormone test run on Theranos proprietary machines failed 87 percent of quality control checks. The WSJ also reveals that a test used to detect prostate cancer failed quality control verifications 22 percent of the time between April and May 2015.

The startup has already submitted a correction plan for these deficiencies. These changes included hiring a new lab director and voiding patient "results associated with any findings that were not consistent with the quality standards the lab holds itself to today," Buchanan told The Verge. Theranos also told the WSJ last month that it had notified all patients who were affected by the findings.

These gestures may not be enough to save Theranos' reputation. In January, Theranos' most prominent partner, the drugstore chain Walgreens, asked Theranos to stop sending blood samples collected at its clinics inside Walgreens stores to its Newark Lab. Walgreens has suspended Theranos laboratory testing services at its store in Palo Alto, California. One month later, the Financial Times reported that the drugstore company was trying to sever ties with the company. Theranos currently operates 40 clinics inside Walgreens stores in Arizona.

Today’s Storystream

Feed refreshed Two hours ago Midjourneys

External Link
Emma RothTwo hours ago
Celsius’ CEO is out.

Alex Mashinsky, the head of the bankrupt crypto lending firm Celsius, announced his resignation today, but not after patting himself on the back for working “tirelessly to help the company.”

In Mashinsky’s eyes, I guess that means designing “Unbankrupt yourself” t-shirts on Cafepress and then selling them to a user base that just had their funds vaporized.

At least customers of the embattled Voyager Digital crypto firm are in slightly better shape, as the Sam Bankman-Fried-owned FTX just bought out the company’s assets.

Mary Beth GriggsTwo hours ago
NASA’s SLS rocket is secure as Hurricane Ian barrels towards Florida.

The rocket — and the Orion spacecraft on top — are now back inside the massive Vehicle Assembly Building. Facing menacing forecasts, NASA decided to roll it away from the launchpad yesterday.

External Link
Andrew J. Hawkins1:30 PM UTC
Harley-Davidson’s electric motorcycle brand is about to go public via SPAC

LiveWire has completed its merger with a blank-check company and will make its debut on the New York Stock Exchange today. Harley-Davison CEO Jochen Zeitz called it “a proud and exciting milestone for LiveWire towards its ambition to become the most desirable electric motorcycle brand in the world.” Hopefully it also manages to avoid the cash crunch of other EV SPACs, like Canoo, Arrival, Faraday Future, and Lordstown.

The Verge
Andrew Webster1:06 PM UTC
“There’s an endless array of drama going on surrounding Twitch right now.”

That’s Ryan Morrison, CEO of Evolved Talent Agency, which represents some of the biggest streamers around. And he’s right — as you can read in this investigation from my colleague Ash Parrish, who looked into just what’s going on with Amazon’s livestreaming service.

The Verge
Richard Lawler12:59 PM UTC
Green light.

NASA’s spacecraft crashed, and everyone is very happy about it.

Otherwise, Mitchell Clark is kicking off the day with a deeper look at Dish Network’s definitely-real 5G wireless service , and Walmart’s metaverse vision in Roblox is not looking good at all.

External Link
Jess Weatherbed11:49 AM UTC
Won’t anyone think of the billionaires?

Forbes reports that rising inflation and falling stock prices have collectively cost members of the Forbes 400 US rich list $500 billion in 2022 with tech tycoons suffering the biggest losses.

Jeff Bezos (worth $151 billion) lost $50 billion, Google’s Larry Page and Sergey Brin (worth a collective $182b) lost almost $60b, Mark Zuckerberg (worth $57.7b) lost $76.8b, and Twitter co-founder Jack Dorsey (worth $4.5b) lost $10.4b. Former Microsoft CEO Steve Ballmer (worth $83b) lost $13.5b while his ex-boss Bill Gates (worth $106b) lost $28b, albeit $20b of that via charity donations.

Richard Lawler12:00 AM UTC
A direct strike at 14,000 mph.

The Double Asteroid Redirection Test (DART) scored a hit on the asteroid Dimorphos, but as Mary Beth Griggs explains, the real science work is just beginning.

Now planetary scientists will wait to see how the impact changed the asteroid’s orbit, and to download pictures from DART’s LICIACube satellite which had a front-row seat to the crash.

The Verge
We’re about an hour away from a space crash.

At 7:14PM ET, a NASA spacecraft is going to smash into an asteroid! Coverage of the collision — called the Double Asteroid Redirection Test — is now live.

Emma RothSep 26
There’s a surprise in the sky tonight.

Jupiter will be about 367 million miles away from Earth this evening. While that may seem like a long way, it’s the closest it’s been to our home planet since 1963.

During this time, Jupiter will be visible to the naked eye (but binoculars can help). You can check where and when you can get a glimpse of the gas giant from this website.